Latest Articles
'A new world is coming': Plans for NHS 'online hospital’ to tackle prostate problems and menopause unveiled - here's when the new service is due to be available for patients - Shropshire Star
'A new world is coming': Plans for NHS 'online hospital’ to tackle prostate problems and menopause unveiled - here's when the new service is due to be available for patients …
Published: Jan. 5, 2026, 10:30 p.m.
Tenneyce Sprecher's Memorial Wall - Ryan Funeral Homes
Tenneyce Sprecher's Memorial Wall Ryan Funeral Homes
Published: Jan. 5, 2026, 8:26 p.m.
Petition against introduction of digital ID cards most signed in Hemel Hempstead constituency - Hemel Today
Petition against introduction of digital ID cards most signed in Hemel Hempstead constituency Hemel Today
Published: Jan. 5, 2026, 3:43 p.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology
Published: Jan. 5, 2026, 1:07 p.m.
Petition urges Government to introduce menstrual leave - FemTech World
Petition urges Government to introduce menstrual leave FemTech World
Published: Jan. 5, 2026, 9:10 a.m.
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer - Oncodaily
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer Oncodaily
Published: Jan. 3, 2026, 8:59 p.m.
Autologous CD133+ Stem Cells Trial for Asherman - BIOENGINEER.ORG
Autologous CD133+ Stem Cells Trial for Asherman BIOENGINEER.ORG
Published: Jan. 3, 2026, 7:41 a.m.
Autologous CD133+ Stem Cells Trial for Asherman - Bioengineer.org
Autologous CD133+ Stem Cells Trial for Asherman Bioengineer.org
Published: Jan. 3, 2026, 7:41 a.m.
Link copied to clipboard!